| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 43 | 2024 | 490 | 12.170 |
Why?
|
| Renal Insufficiency, Chronic | 38 | 2023 | 293 | 9.220 |
Why?
|
| Living Donors | 31 | 2024 | 61 | 8.750 |
Why?
|
| Kidney Failure, Chronic | 37 | 2022 | 534 | 7.170 |
Why?
|
| Renal Dialysis | 32 | 2023 | 275 | 5.300 |
Why?
|
| Kidney Diseases | 19 | 2022 | 243 | 5.090 |
Why?
|
| Healthcare Disparities | 20 | 2022 | 180 | 4.040 |
Why?
|
| Hypertension | 28 | 2023 | 980 | 4.040 |
Why?
|
| Patient Education as Topic | 16 | 2019 | 245 | 3.850 |
Why?
|
| Humans | 195 | 2024 | 32262 | 3.560 |
Why?
|
| Kidney | 18 | 2023 | 521 | 3.390 |
Why?
|
| Health Knowledge, Attitudes, Practice | 16 | 2018 | 316 | 3.090 |
Why?
|
| Attitude to Health | 15 | 2020 | 137 | 3.050 |
Why?
|
| United States | 71 | 2023 | 4068 | 2.750 |
Why?
|
| Health Services Accessibility | 11 | 2022 | 242 | 2.730 |
Why?
|
| Tissue and Organ Procurement | 10 | 2022 | 88 | 2.600 |
Why?
|
| Primary Health Care | 12 | 2022 | 232 | 2.490 |
Why?
|
| Family | 10 | 2022 | 112 | 2.270 |
Why?
|
| Nephrology | 9 | 2021 | 33 | 2.100 |
Why?
|
| Middle Aged | 85 | 2023 | 11837 | 2.080 |
Why?
|
| Diabetes Mellitus | 8 | 2023 | 390 | 2.030 |
Why?
|
| Renal Replacement Therapy | 7 | 2021 | 18 | 1.960 |
Why?
|
| Adult | 70 | 2023 | 9252 | 1.950 |
Why?
|
| Female | 98 | 2023 | 19935 | 1.940 |
Why?
|
| Socioeconomic Factors | 17 | 2023 | 388 | 1.900 |
Why?
|
| Cross-Sectional Studies | 28 | 2023 | 1478 | 1.780 |
Why?
|
| Residence Characteristics | 5 | 2023 | 178 | 1.780 |
Why?
|
| Decision Making | 10 | 2018 | 189 | 1.780 |
Why?
|
| Male | 93 | 2023 | 19429 | 1.770 |
Why?
|
| Self Care | 6 | 2023 | 97 | 1.730 |
Why?
|
| Delivery of Health Care | 6 | 2022 | 167 | 1.690 |
Why?
|
| Kidney Function Tests | 6 | 2023 | 101 | 1.670 |
Why?
|
| Patient Participation | 6 | 2021 | 90 | 1.600 |
Why?
|
| Aged | 59 | 2022 | 10249 | 1.500 |
Why?
|
| Glomerular Filtration Rate | 19 | 2021 | 302 | 1.420 |
Why?
|
| Tissue Donors | 8 | 2022 | 186 | 1.380 |
Why?
|
| Communication | 7 | 2021 | 128 | 1.320 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2022 | 158 | 1.130 |
Why?
|
| Trust | 3 | 2020 | 43 | 1.130 |
Why?
|
| Patient-Centered Care | 4 | 2018 | 75 | 1.120 |
Why?
|
| Telemedicine | 4 | 2019 | 122 | 1.110 |
Why?
|
| Medication Adherence | 2 | 2020 | 160 | 1.060 |
Why?
|
| Asthma | 2 | 2020 | 262 | 1.030 |
Why?
|
| Referral and Consultation | 7 | 2022 | 137 | 1.030 |
Why?
|
| Social Work | 4 | 2015 | 8 | 0.960 |
Why?
|
| Cooperative Behavior | 4 | 2019 | 83 | 0.930 |
Why?
|
| Antihypertensive Agents | 6 | 2021 | 363 | 0.920 |
Why?
|
| Awards and Prizes | 2 | 2022 | 12 | 0.910 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 161 | 0.880 |
Why?
|
| Renal Insufficiency | 3 | 2020 | 57 | 0.880 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 129 | 0.850 |
Why?
|
| Biomedical Research | 6 | 2021 | 178 | 0.830 |
Why?
|
| Physician-Patient Relations | 5 | 2018 | 179 | 0.820 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2021 | 46 | 0.810 |
Why?
|
| Registries | 8 | 2023 | 294 | 0.810 |
Why?
|
| Young Adult | 20 | 2021 | 2643 | 0.800 |
Why?
|
| Liver Transplantation | 3 | 2023 | 185 | 0.800 |
Why?
|
| Blood Pressure | 10 | 2023 | 864 | 0.800 |
Why?
|
| Risk Factors | 30 | 2021 | 3933 | 0.790 |
Why?
|
| Interdisciplinary Communication | 3 | 2015 | 59 | 0.790 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2023 | 5 | 0.780 |
Why?
|
| Cardiovascular Diseases | 12 | 2023 | 1159 | 0.760 |
Why?
|
| Disease Progression | 10 | 2022 | 591 | 0.760 |
Why?
|
| Information Dissemination | 3 | 2021 | 52 | 0.750 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 312 | 0.740 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2022 | 11 | 0.730 |
Why?
|
| Informed Consent | 2 | 2012 | 44 | 0.700 |
Why?
|
| American Medical Association | 1 | 2021 | 3 | 0.700 |
Why?
|
| Aged, 80 and over | 21 | 2021 | 3893 | 0.690 |
Why?
|
| Editorial Policies | 1 | 2021 | 14 | 0.690 |
Why?
|
| Health Status Disparities | 7 | 2022 | 128 | 0.690 |
Why?
|
| Financial Support | 2 | 2018 | 5 | 0.670 |
Why?
|
| Environmental Health | 1 | 2020 | 7 | 0.660 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 42 | 0.660 |
Why?
|
| Treatment Outcome | 19 | 2023 | 3408 | 0.650 |
Why?
|
| Patient Selection | 2 | 2022 | 272 | 0.650 |
Why?
|
| Coronavirus | 1 | 2020 | 2 | 0.650 |
Why?
|
| Quality Indicators, Health Care | 3 | 2020 | 62 | 0.650 |
Why?
|
| Health Behavior | 2 | 2019 | 213 | 0.650 |
Why?
|
| Prevalence | 10 | 2023 | 955 | 0.640 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 90 | 0.640 |
Why?
|
| Public Health | 3 | 2019 | 91 | 0.630 |
Why?
|
| Chronic Disease | 9 | 2023 | 413 | 0.610 |
Why?
|
| Guideline Adherence | 3 | 2014 | 109 | 0.610 |
Why?
|
| Continuity of Patient Care | 2 | 2020 | 73 | 0.610 |
Why?
|
| Iron | 3 | 2017 | 94 | 0.590 |
Why?
|
| Vulnerable Populations | 2 | 2019 | 37 | 0.590 |
Why?
|
| Research Design | 4 | 2015 | 316 | 0.580 |
Why?
|
| Attitude of Health Personnel | 4 | 2015 | 183 | 0.580 |
Why?
|
| Adolescent | 14 | 2021 | 3509 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 98 | 0.570 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 95 | 0.570 |
Why?
|
| Quality of Health Care | 2 | 2015 | 148 | 0.570 |
Why?
|
| Dialysis | 1 | 2018 | 3 | 0.570 |
Why?
|
| Fluorocarbon Polymers | 1 | 2018 | 2 | 0.570 |
Why?
|
| Baltimore | 8 | 2019 | 50 | 0.570 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 13 | 0.570 |
Why?
|
| Comparative Effectiveness Research | 3 | 2013 | 28 | 0.570 |
Why?
|
| Mass Screening | 5 | 2011 | 256 | 0.560 |
Why?
|
| Energy Intake | 1 | 2019 | 122 | 0.550 |
Why?
|
| Patient Transfer | 1 | 2018 | 41 | 0.550 |
Why?
|
| Environmental Exposure | 1 | 2018 | 60 | 0.550 |
Why?
|
| Cultural Competency | 3 | 2014 | 15 | 0.540 |
Why?
|
| Risk Assessment | 13 | 2021 | 1423 | 0.540 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 115 | 0.530 |
Why?
|
| Diet | 2 | 2022 | 383 | 0.530 |
Why?
|
| Health Services Research | 2 | 2012 | 81 | 0.530 |
Why?
|
| Patient Preference | 1 | 2018 | 48 | 0.530 |
Why?
|
| Social Support | 4 | 2019 | 180 | 0.500 |
Why?
|
| Absenteeism | 1 | 2016 | 10 | 0.490 |
Why?
|
| Efficiency | 1 | 2016 | 17 | 0.490 |
Why?
|
| Patient Discharge | 2 | 2020 | 204 | 0.480 |
Why?
|
| Prospective Studies | 15 | 2022 | 2315 | 0.480 |
Why?
|
| Physical Examination | 2 | 2007 | 83 | 0.470 |
Why?
|
| Internship and Residency | 1 | 2020 | 317 | 0.470 |
Why?
|
| Evidence-Based Medicine | 4 | 2012 | 212 | 0.470 |
Why?
|
| Health Promotion | 3 | 2013 | 242 | 0.470 |
Why?
|
| Waiting Lists | 6 | 2022 | 35 | 0.470 |
Why?
|
| Patient Care Team | 3 | 2018 | 123 | 0.470 |
Why?
|
| Coronary Disease | 4 | 2020 | 226 | 0.470 |
Why?
|
| Longitudinal Studies | 8 | 2023 | 759 | 0.460 |
Why?
|
| Minority Groups | 3 | 2016 | 81 | 0.460 |
Why?
|
| Preventive Health Services | 4 | 2015 | 39 | 0.450 |
Why?
|
| Health Services Needs and Demand | 2 | 2014 | 83 | 0.450 |
Why?
|
| Problem Solving | 3 | 2023 | 26 | 0.450 |
Why?
|
| Income | 7 | 2020 | 66 | 0.450 |
Why?
|
| Creatinine | 3 | 2015 | 191 | 0.450 |
Why?
|
| Health Care Costs | 1 | 2016 | 122 | 0.450 |
Why?
|
| Depression | 4 | 2023 | 425 | 0.440 |
Why?
|
| Clinical Competence | 2 | 2017 | 329 | 0.430 |
Why?
|
| Peritoneal Dialysis | 2 | 2013 | 22 | 0.410 |
Why?
|
| Family Relations | 2 | 2019 | 19 | 0.410 |
Why?
|
| Patient Satisfaction | 5 | 2018 | 230 | 0.400 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 40 | 0.400 |
Why?
|
| Retrospective Studies | 9 | 2023 | 3609 | 0.390 |
Why?
|
| Time Factors | 15 | 2020 | 2203 | 0.390 |
Why?
|
| Incidence | 10 | 2020 | 1241 | 0.380 |
Why?
|
| Needs Assessment | 1 | 2013 | 78 | 0.370 |
Why?
|
| Blood Donors | 2 | 2002 | 11 | 0.360 |
Why?
|
| Comorbidity | 10 | 2020 | 563 | 0.360 |
Why?
|
| Research | 1 | 2012 | 81 | 0.360 |
Why?
|
| Cohort Studies | 8 | 2023 | 1839 | 0.360 |
Why?
|
| Public Opinion | 1 | 2012 | 17 | 0.360 |
Why?
|
| Prejudice | 4 | 2009 | 45 | 0.350 |
Why?
|
| Research Support as Topic | 2 | 2022 | 32 | 0.350 |
Why?
|
| Proteinuria | 4 | 2009 | 52 | 0.350 |
Why?
|
| Hospitalization | 8 | 2022 | 475 | 0.350 |
Why?
|
| Organ Transplantation | 2 | 2022 | 67 | 0.350 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 20 | 0.350 |
Why?
|
| Cultural Diversity | 2 | 2021 | 17 | 0.340 |
Why?
|
| Intention | 1 | 2011 | 30 | 0.340 |
Why?
|
| Veterans | 3 | 2016 | 64 | 0.340 |
Why?
|
| Prognosis | 8 | 2022 | 1529 | 0.340 |
Why?
|
| Quality of Life | 5 | 2021 | 968 | 0.330 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 246 | 0.330 |
Why?
|
| Vitamin D | 3 | 2023 | 186 | 0.330 |
Why?
|
| Follow-Up Studies | 8 | 2014 | 2238 | 0.320 |
Why?
|
| Social Justice | 4 | 2021 | 16 | 0.310 |
Why?
|
| Cadaver | 3 | 2006 | 151 | 0.310 |
Why?
|
| Albuminuria | 4 | 2014 | 172 | 0.300 |
Why?
|
| Self Concept | 1 | 2009 | 45 | 0.290 |
Why?
|
| Social Class | 3 | 2020 | 90 | 0.290 |
Why?
|
| Logistic Models | 5 | 2019 | 743 | 0.280 |
Why?
|
| Odds Ratio | 3 | 2022 | 455 | 0.270 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 31 | 0.260 |
Why?
|
| Health Status | 3 | 2022 | 356 | 0.260 |
Why?
|
| Stroke | 4 | 2020 | 691 | 0.260 |
Why?
|
| Resource Allocation | 1 | 2007 | 8 | 0.260 |
Why?
|
| Nutritional Status | 2 | 2019 | 73 | 0.250 |
Why?
|
| Qualitative Research | 4 | 2019 | 179 | 0.250 |
Why?
|
| Maryland | 6 | 2014 | 27 | 0.240 |
Why?
|
| Motivation | 4 | 2014 | 121 | 0.230 |
Why?
|
| Urinalysis | 2 | 2011 | 19 | 0.230 |
Why?
|
| Anemia | 2 | 2017 | 50 | 0.220 |
Why?
|
| Nephrectomy | 2 | 2006 | 123 | 0.220 |
Why?
|
| Anatomy | 1 | 2004 | 4 | 0.220 |
Why?
|
| Risk-Taking | 1 | 2005 | 96 | 0.220 |
Why?
|
| Insurance, Health | 4 | 2010 | 95 | 0.220 |
Why?
|
| Atherosclerosis | 2 | 2020 | 821 | 0.210 |
Why?
|
| Brain Ischemia | 2 | 2016 | 158 | 0.210 |
Why?
|
| Hospitals | 3 | 2016 | 95 | 0.210 |
Why?
|
| Focus Groups | 3 | 2014 | 123 | 0.210 |
Why?
|
| Systems Analysis | 1 | 2023 | 3 | 0.210 |
Why?
|
| Educational Status | 4 | 2020 | 167 | 0.200 |
Why?
|
| Databases, Factual | 4 | 2020 | 367 | 0.200 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2023 | 3 | 0.200 |
Why?
|
| Communication Barriers | 2 | 2015 | 18 | 0.200 |
Why?
|
| Religion | 4 | 2021 | 28 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2012 | 544 | 0.200 |
Why?
|
| Obesity | 2 | 2022 | 1111 | 0.200 |
Why?
|
| Bayes Theorem | 1 | 2023 | 82 | 0.200 |
Why?
|
| Graft Survival | 3 | 2021 | 293 | 0.200 |
Why?
|
| Radiopharmaceuticals | 1 | 2023 | 95 | 0.200 |
Why?
|
| Violence | 1 | 2023 | 17 | 0.190 |
Why?
|
| Statistical Distributions | 1 | 2002 | 5 | 0.190 |
Why?
|
| Health Policy | 1 | 2023 | 89 | 0.190 |
Why?
|
| Child | 4 | 2020 | 2430 | 0.180 |
Why?
|
| Professional-Family Relations | 2 | 2012 | 17 | 0.180 |
Why?
|
| North Carolina | 3 | 2021 | 1300 | 0.180 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 35 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 2 | 2020 | 83 | 0.180 |
Why?
|
| Poverty | 3 | 2019 | 105 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1437 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2012 | 553 | 0.170 |
Why?
|
| Behavior Therapy | 1 | 2002 | 102 | 0.170 |
Why?
|
| Research Personnel | 1 | 2021 | 22 | 0.170 |
Why?
|
| Data Collection | 4 | 2013 | 171 | 0.170 |
Why?
|
| Friends | 1 | 2021 | 8 | 0.170 |
Why?
|
| Eligibility Determination | 1 | 2021 | 18 | 0.170 |
Why?
|
| Models, Statistical | 1 | 2022 | 187 | 0.170 |
Why?
|
| Cities | 1 | 2020 | 7 | 0.170 |
Why?
|
| Counseling | 2 | 2019 | 94 | 0.170 |
Why?
|
| Hypoglycemia | 1 | 2021 | 43 | 0.160 |
Why?
|
| Urban Population | 2 | 2019 | 91 | 0.160 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2020 | 28 | 0.160 |
Why?
|
| Health Care Rationing | 2 | 2012 | 11 | 0.160 |
Why?
|
| Heart Transplantation | 1 | 2020 | 33 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 54 | 0.160 |
Why?
|
| Sleep | 1 | 2020 | 87 | 0.160 |
Why?
|
| Allostasis | 1 | 2020 | 12 | 0.160 |
Why?
|
| Peer Group | 2 | 2019 | 47 | 0.160 |
Why?
|
| Ownership | 1 | 2019 | 13 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2020 | 42 | 0.150 |
Why?
|
| Internal Medicine | 1 | 2020 | 53 | 0.150 |
Why?
|
| Resuscitation | 1 | 2020 | 66 | 0.150 |
Why?
|
| Mississippi | 4 | 2020 | 38 | 0.150 |
Why?
|
| Community-Based Participatory Research | 3 | 2016 | 114 | 0.150 |
Why?
|
| Potassium, Dietary | 1 | 2019 | 5 | 0.150 |
Why?
|
| Phosphorus, Dietary | 1 | 2019 | 3 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2019 | 20 | 0.150 |
Why?
|
| Perception | 3 | 2014 | 99 | 0.150 |
Why?
|
| Computers, Handheld | 1 | 2019 | 15 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 21 | 0.150 |
Why?
|
| Psychology | 1 | 2019 | 25 | 0.150 |
Why?
|
| Magnesium | 1 | 2019 | 29 | 0.140 |
Why?
|
| Survival Rate | 4 | 2014 | 892 | 0.140 |
Why?
|
| Patient Advocacy | 1 | 2018 | 11 | 0.140 |
Why?
|
| Health Personnel | 1 | 2020 | 112 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 43 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 167 | 0.140 |
Why?
|
| Blood Pressure Determination | 2 | 2014 | 106 | 0.140 |
Why?
|
| Interviews as Topic | 2 | 2019 | 194 | 0.140 |
Why?
|
| Commerce | 1 | 2019 | 69 | 0.140 |
Why?
|
| Reminder Systems | 1 | 2018 | 23 | 0.140 |
Why?
|
| Societies, Medical | 2 | 2009 | 153 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2018 | 74 | 0.140 |
Why?
|
| Risk | 1 | 2019 | 305 | 0.140 |
Why?
|
| Health Care Surveys | 3 | 2014 | 184 | 0.130 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 34 | 0.130 |
Why?
|
| Physicians | 2 | 2014 | 163 | 0.130 |
Why?
|
| Documentation | 1 | 2017 | 39 | 0.130 |
Why?
|
| Attitude | 2 | 2011 | 37 | 0.130 |
Why?
|
| Costs and Cost Analysis | 2 | 2009 | 106 | 0.130 |
Why?
|
| Age Factors | 4 | 2021 | 1178 | 0.130 |
Why?
|
| Trace Elements | 1 | 2017 | 6 | 0.130 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 772 | 0.130 |
Why?
|
| Videoconferencing | 1 | 2017 | 7 | 0.130 |
Why?
|
| Self-Help Groups | 1 | 2017 | 11 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2002 | 818 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2017 | 54 | 0.120 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 16 | 0.120 |
Why?
|
| Government Programs | 1 | 2016 | 11 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 287 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2018 | 863 | 0.120 |
Why?
|
| Public Policy | 1 | 2016 | 31 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2019 | 309 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 395 | 0.120 |
Why?
|
| Donor Selection | 1 | 2015 | 28 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2015 | 179 | 0.110 |
Why?
|
| Food Supply | 1 | 2015 | 64 | 0.110 |
Why?
|
| Models, Organizational | 1 | 2015 | 18 | 0.110 |
Why?
|
| Iron Compounds | 1 | 2014 | 2 | 0.110 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2014 | 5 | 0.110 |
Why?
|
| Nurses | 1 | 2014 | 14 | 0.110 |
Why?
|
| Troponin I | 1 | 2014 | 20 | 0.100 |
Why?
|
| Random Allocation | 2 | 2006 | 247 | 0.100 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 86 | 0.100 |
Why?
|
| Prescriptions | 1 | 2013 | 15 | 0.100 |
Why?
|
| Systole | 1 | 2014 | 94 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2014 | 154 | 0.100 |
Why?
|
| Disease Management | 2 | 2017 | 129 | 0.100 |
Why?
|
| Heart Failure | 2 | 2011 | 728 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2013 | 26 | 0.100 |
Why?
|
| Pamphlets | 1 | 2012 | 5 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2012 | 10 | 0.090 |
Why?
|
| African Americans | 1 | 2019 | 1335 | 0.090 |
Why?
|
| Age Distribution | 2 | 2021 | 194 | 0.090 |
Why?
|
| Acetaminophen | 1 | 2012 | 19 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 99 | 0.090 |
Why?
|
| Video Recording | 1 | 2012 | 61 | 0.090 |
Why?
|
| Fever | 1 | 2012 | 59 | 0.090 |
Why?
|
| Sex Factors | 3 | 2007 | 656 | 0.090 |
Why?
|
| Sterols | 2 | 2023 | 3 | 0.090 |
Why?
|
| Goals | 1 | 2012 | 34 | 0.090 |
Why?
|
| Inpatients | 1 | 2012 | 83 | 0.090 |
Why?
|
| Parathyroid Hormone | 2 | 2023 | 45 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2012 | 84 | 0.090 |
Why?
|
| Employment | 2 | 2002 | 44 | 0.090 |
Why?
|
| Health Education | 1 | 2012 | 149 | 0.090 |
Why?
|
| Cause of Death | 3 | 2020 | 236 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2012 | 476 | 0.090 |
Why?
|
| Disclosure | 1 | 2011 | 31 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2014 | 415 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2011 | 77 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 551 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2002 | 471 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 821 | 0.080 |
Why?
|
| Physician's Role | 1 | 2011 | 41 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2017 | 133 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 61 | 0.070 |
Why?
|
| Civil Rights | 1 | 2009 | 7 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2021 | 132 | 0.070 |
Why?
|
| Awareness | 1 | 2008 | 23 | 0.070 |
Why?
|
| Patients | 1 | 2008 | 46 | 0.070 |
Why?
|
| Medicare | 1 | 2009 | 218 | 0.070 |
Why?
|
| Pancreas Transplantation | 1 | 2009 | 245 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 267 | 0.070 |
Why?
|
| Genotype | 2 | 2019 | 702 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2007 | 191 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2009 | 650 | 0.060 |
Why?
|
| Medicaid | 2 | 2023 | 101 | 0.060 |
Why?
|
| Telephone | 1 | 2006 | 61 | 0.060 |
Why?
|
| Canada | 1 | 2006 | 63 | 0.060 |
Why?
|
| Surgical Instruments | 1 | 2006 | 25 | 0.060 |
Why?
|
| Linear Models | 2 | 2009 | 426 | 0.060 |
Why?
|
| Altruism | 1 | 2005 | 5 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2021 | 174 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2017 | 59 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2006 | 95 | 0.060 |
Why?
|
| Length of Stay | 2 | 2007 | 321 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 500 | 0.050 |
Why?
|
| Health Priorities | 2 | 2014 | 16 | 0.050 |
Why?
|
| Diffusion of Innovation | 2 | 2014 | 33 | 0.050 |
Why?
|
| Causality | 2 | 2013 | 37 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2003 | 33 | 0.050 |
Why?
|
| Markov Chains | 1 | 2003 | 31 | 0.050 |
Why?
|
| Naphthalenes | 1 | 2023 | 53 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2005 | 854 | 0.050 |
Why?
|
| Vitamins | 1 | 2023 | 70 | 0.050 |
Why?
|
| Probability | 1 | 2003 | 155 | 0.050 |
Why?
|
| Marriage | 1 | 2002 | 6 | 0.050 |
Why?
|
| Occupations | 1 | 2002 | 7 | 0.050 |
Why?
|
| Fear | 1 | 2002 | 42 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 67 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 47 | 0.040 |
Why?
|
| Social Environment | 1 | 2021 | 75 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2002 | 80 | 0.040 |
Why?
|
| Hypotension, Orthostatic | 1 | 2021 | 12 | 0.040 |
Why?
|
| Medical Assistance | 1 | 2021 | 3 | 0.040 |
Why?
|
| Computer Security | 1 | 2021 | 8 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 16 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2001 | 2 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2001 | 8 | 0.040 |
Why?
|
| Government Regulation | 1 | 2021 | 29 | 0.040 |
Why?
|
| Actigraphy | 1 | 2020 | 15 | 0.040 |
Why?
|
| Minerals | 1 | 2020 | 14 | 0.040 |
Why?
|
| Polysomnography | 1 | 2020 | 39 | 0.040 |
Why?
|
| Phosphates | 1 | 2020 | 26 | 0.040 |
Why?
|
| Propensity Score | 1 | 2020 | 47 | 0.040 |
Why?
|
| Diabetes Complications | 2 | 2014 | 171 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 335 | 0.040 |
Why?
|
| Universities | 1 | 2021 | 149 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 292 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2012 | 141 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 186 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 57 | 0.040 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2019 | 9 | 0.040 |
Why?
|
| History, 20th Century | 2 | 2009 | 74 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 117 | 0.040 |
Why?
|
| Insulin | 1 | 2021 | 359 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2020 | 197 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2019 | 248 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2018 | 91 | 0.030 |
Why?
|
| Financing, Organized | 1 | 2017 | 17 | 0.030 |
Why?
|
| Emotions | 1 | 2018 | 55 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 52 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 273 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 45 | 0.030 |
Why?
|
| Indians, North American | 1 | 2016 | 75 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 466 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2016 | 15 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 42 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 227 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2015 | 50 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2015 | 22 | 0.030 |
Why?
|
| Kenya | 1 | 2015 | 21 | 0.030 |
Why?
|
| Consumer Health Information | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 120 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2015 | 144 | 0.030 |
Why?
|
| International Cooperation | 1 | 2014 | 31 | 0.030 |
Why?
|
| Ferritins | 1 | 2014 | 38 | 0.030 |
Why?
|
| Food Preferences | 1 | 2014 | 34 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 536 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2014 | 12 | 0.030 |
Why?
|
| Career Choice | 1 | 2014 | 43 | 0.030 |
Why?
|
| Community Health Services | 1 | 2014 | 47 | 0.030 |
Why?
|
| Health Literacy | 1 | 2014 | 27 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 33 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 99 | 0.030 |
Why?
|
| Education, Medical | 1 | 2014 | 69 | 0.030 |
Why?
|
| Institutionalization | 1 | 2013 | 2 | 0.030 |
Why?
|
| Uremia | 1 | 2013 | 9 | 0.030 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hyperkalemia | 1 | 2013 | 15 | 0.030 |
Why?
|
| Systems Integration | 1 | 2013 | 11 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2013 | 33 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 22 | 0.020 |
Why?
|
| Massachusetts | 1 | 2012 | 27 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2012 | 15 | 0.020 |
Why?
|
| Mortality | 1 | 2013 | 122 | 0.020 |
Why?
|
| Animals | 2 | 2014 | 8196 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 139 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 756 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 716 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 556 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 11 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2009 | 14 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 173 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 57 | 0.020 |
Why?
|
| Marital Status | 1 | 2007 | 21 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 2006 | 11 | 0.010 |
Why?
|
| Korea | 1 | 2005 | 3 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 198 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 262 | 0.010 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2003 | 23 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 484 | 0.010 |
Why?
|
| Societies, Scientific | 1 | 2001 | 16 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2001 | 55 | 0.010 |
Why?
|